Composition and Localization of Dendritic mRNAs in Fragile X Syndrome

With a $80,000 grant from FRAXA Research Foundation over 2 years, Drs. Smith and Wang are investigating which proteins, as well as the mRNA’s that code those proteins, are dysregulated in Fragile X. They have developed a elegant system to visualize the proteins and mRNA’s and determine where they are spacially in the neuron. This will help to better understand the root causes of Fragile X syndrome and to design targeted treatments.

$80,000 Grant
Stephen Smith, PhD
Principal Investigator
Stanford University
2008-2009 FRAXA Research Grant
$80,000 over 2 Years

A Quantitative Study by Array Tomographic Florescent In Situ Hybridization

by Gordon Wang, 8/1/2008

Fragile X syndrome is caused by the malfunction of a fundamental cellular process, the ability of cells to regulate spatially distinct pools of messenger RNA (mRNA). One of the cell types most affected is the neuron. This highly asymmetric cell type relies upon a tightly orchestrated network of proteins and RNAs to acutely and focally deal with its basic function, which is to process incoming information and to propagate it with fidelity. Defects in this regulatory network, however small (for example, Fragile X syndrome is caused by the loss of a single RNA binding protein) can have complex and life altering consequences. In the case of Fragile X, the result is mental retardation.

One of the major obstacles to treating Fragile X is in understanding the identities of the mRNAs disturbed, and where this disturbance is occurring. Our research will focus on the development of florescent in situ hybridization and Array Tomography, a new high resolution imaging paradigm, to quantify the nature of this disruption through high resolution and high throughput visualization of proteins and mRNAs on a subcellular level. This will allow us to determine, in intact tissue, the identities of the affected mRNAs and the nature of their affliction. This will help us better understand the root causes of Fragile X syndrome and to design targeted treatments.

Gordon Wang, PhD
FRAXA Postdoctoral Fellow

Explore Current Fragile X Research

FRAXA-funded researchers around the world are leading the way towards effective treatments and ultimately a cure.